Vandria creates mitophagy inducers that renew cells to address ageing and chronic disorders.
Vandria has raised $10.1M in total funding. The most recent round was Series A. The last funding was announced in August 2024.
Vandria's investors include +ND Capital, Innosuisse, Eurostars, Hevolution Foundation, Dolby Family Ventures.
Vandria is headquartered in Lausanne, Switzerland.
Vandria creates mitophagy inducers that renew cells to address ageing and chronic disorders.
Vandria is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vandria — Funding & Investors." VCBacked, August 21, 2024, https://www.vcbacked.co/company/vandria. Accessed August 14, 2026.
VCBacked. (2024). Vandria — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/vandria
{{cite web |title=Vandria — Funding & Investors |url=https://www.vcbacked.co/company/vandria |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated